NDC 50090-7339-01 - Ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7339
- Requested NDC
- 50090-7339-01
- Package NDCs from labels
- 50090-7339-0, 50090-7339-1, 50090-7339-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ezetimibe - A-S Medication Solutions | A-S Medication Solutions | 2024-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7339-0 | Ezetimibe | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 50090-7339-1 | Ezetimibe | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7339 | EZETIMIBE TABLET [A-S MEDICATION SOLUTIONS] | 1 | Current NDC, 2 package rows | 20241023_5877150f-2807-435e-8e5b-a07dc7dbfd27.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7339-0 | EA - Each | 50090-7339 | 3c9f6bf5-fc01-48cd-956a-a64eb94afe2d | 1 | 2024-11-05 |
| 50090-7339-1 | EA - Each | 50090-7339 | 4a0bfdb3-7e11-4cdb-a8e8-25ae48534ed2 | 1 | 2024-11-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Dr.Reddys Laboratories Inc | 023ca87a-1b04-8c17-dc4f-e2758b0771e2 | 2025-07-18 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | c92292f5-5444-4247-927e-db7bf6816109 | 2025-07-17 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Ascend Laboratories, LLC | 206d702c-b09a-4555-972b-6555d6d6d6e6 | 2025-06-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 3a80b668-51cd-42be-8497-8712b0508422 | 2025-05-12 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Ascend Laboratories, LLC | c90e8c96-e130-42d7-bf0d-5833652e40d5 | 2025-05-02 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Aurobindo Pharma Limited | 726b1e63-437a-4b3b-b773-3ac47a5c0f38 | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | NorthStar Rx LLC | 5f5644a9-e019-4e5d-ab6f-3d30b1024c5a | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 55b18d8f-40e0-48ba-baf1-79a0d1bb2ee2 | 2025-03-01 | Warnings, Adverse reactions | ANDA078560 349556 EOR26LQQ24 |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
| Ezetimibe | EZETIMIBE | Amneal Pharmaceuticals NY LLC | 3fadf4e9-017d-4ccd-91dc-a89b981eb138 | 2025-02-10 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| ezetimibe | EZETIMIBE | Zydus Lifesciences Limited | de814dcd-4759-4e9c-a650-335fb885a79d | 2024-11-28 | 349556 EOR26LQQ24 | |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2024-10-25 | Warnings | FZ989GH94E |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Aurobindo Pharma Limited | 79dadfde-35c7-4937-9c82-1728fb6be2fb | 2024-10-22 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 5877150f-2807-435e-8e5b-a07dc7dbfd27 | 2024-10-21 | Warnings, Adverse reactions | ANDA078560 50090-7339-0 50090-7339-1 50090-7339 50090733901 349556 27b6d944-b73a-4d09-9562-ef8f02f49d31 5877150f-2807-435e-8e5b-a07dc7dbfd27 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 1afdb764-c5da-4982-beae-9be61bdcbcdc | 2024-10-21 | Warnings, Adverse reactions | ANDA078560 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 63ecbbf1-a6de-493f-9710-812ff45cb4d3 | 2024-09-29 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Ezetimibe | EZETIMIBE | Glenmark Pharmaceuticals Inc., USA | ac539a72-77e4-419c-b1d9-42002e9cecf7 | 2024-07-31 | Warnings, Adverse reactions | ANDA078560 68462-226 349556 5009c162-91bb-425a-a688-6237c259d33e ac539a72-77e4-419c-b1d9-42002e9cecf7 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | Camber Pharmaceuticals, Inc. | c07fe2e0-dad4-48b5-8a07-7d57a4035ccd | 2024-07-19 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.